$VS Balance Sheet | Understand Stock

$VS

$0.96 +$0.02 (2.08%) Close

$VS Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020
Cash
Receivables, net of allowance (Note 5)
Deferred financing costs (Note 3)
Prepaids and other current assets
Total current assets
Restricted deposit (Note 6)
Deposits
Property and equipment, net (Note 7)
Goodwill (Note 9)
Intangible assets (Note 10)
Total Assets
Accounts payable and accrued liabilities (Note 11, Note 12 and Note 14)
Deferred revenue
Notes payable - Related Party (Note 12)
Lease liability (Note 19)
Total current liabilities
Notes payable (Note 10)
Warrant liability (Note 3)
Total liabilities
Common shares
Commitment to issue shares (Note 13)
Class “A” shares
Reserves (Note 13)
Cumulative translation adjustment
Deficit
Equity (Deficit) total
Non-controlling interest (Note 8)
Total Equity
Assets
Current assets
Contract asset, net – related party
Cash and cash equivalents
Receivables, net of allowance for credit losses
Accounts receivable
Prepaid expenses
Total current assets

Restricted deposit
Deposits
Property and equipment
Intangible asset
Total assets
Liabilities and Equity
Current liabilities
Accounts payable and accrued liabilities
Notes payable - Related Party (Note 12)
Lease liability (Note 19)
Deferred revenue
Total current liabilities

Non-current liabilities
Total liabilities
Stockholders’ equity
Common stock and additional paid in capital, no par value. 200,000,000 authorized shares; 4,901,677 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively
Common stock and additional paid in capital, no par value. 200,000,000 authorized shares; 6,212,646 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Class A Shares
Total common stock and additional paid in capital, no par value. 200,000,000 authorized shares; 6,212,646 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively

Accumulated other comprehensive income
Deficit
Total Versus Systems, Inc. stockholders’ equity
Non-controlling interest
Total stockholders’ equity
Total liabilities, non-controlling interest and stockholders’ equity

Comments